# Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

> **NCT04756687** · — · COMPLETED · sponsor: **Biogen** · enrollment: 1507 (actual)

## Conditions studied

- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Dimethyl fumarate

## Key facts

- **NCT ID:** NCT04756687
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 1507 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756687, "Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04756687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*